[Skip navigation]FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Information About Triptans

Almotriptan (Axert); Eletriptan (Relpax); Frovatriptan (Frova); Naratriptan (Amerge);
Rizatriptan (Maxalt); Sumatriptan (Imitrex); Zolmitriptan (Zomig)

A life-threatening condition called serotonin syndrome can happen when medicines used to treat migraine headaches, 5-hydroxytryptamine receptor agonists (triptans) and medicines used to treat depression, selective serotonin reuptake inhibitors (SSRIs) and selective serotonin/norepinephrine reuptake inhibitors (SNRIs),are used together.

Back to Top     Back to Drug Information

PDF requires the free Adobe Acrobat Reader

Date created: July 19, 2006